Every 30 seconds, someone in the world will experience a flare-up of their asthma or chronic obstructive pulmonary disease (COPD) symptoms.
The antibody drug benralizumab is on the fast track to becoming the first new treatment for certain kinds of asthma and COPD ...
CORBIN — Chronic Obstructive Pulmonary Disease (COPD) is a progressive lung disease that makes breathing increasingly ...
The APG777 + APG990 coformulation has been shown to retain stability, injectability, and convenience of individual components. In preclinical studies it has demonstrated broad inhibition of Type 1, ...
The first new treatment for asthma attacks in 50 years is a drug already available—and it’s 4x more effective than steroid ...
CORBIN — Chronic Obstructive Pulmonary Disease (COPD) is a progressive lung disease that makes breathing increasingly difficult. Common symptoms include chronic coughing, wheezing, phlegm production, ...
I was diagnosed with COPD last year after struggling with multiple symptoms. I quit smoking over 10 years ago, but I'm ...
A new study reveals benralizumab, an injectable drug, shows promise in reducing asthma and COPD flare-ups, outperforming traditional steroid treatments and minimizing side effects. The drug targets ...
The study demonstrated that asthma treatment is safe, with no significant side effects compared to past studies of the drug.
Researchers at King's College London have found a new treatment for asthma attacks, which could be a 'game-changer' for the patients.
To join the webcast, please visit this link or the News & Events page of the Investors section on the Company’s website https://apogeetherapeutics.com. A replay of the webcast will be archived and ...
A study reveals Benralizumab as a new treatment for asthma and COPD, reducing treatment failure rates significantly.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback